Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.

Marur S, Forastiere AA.

Curr Opin Oncol. 2010 May;22(3):206-11. doi: 10.1097/CCO.0b013e328338475c. Review.

PMID:
20216313
[PubMed - indexed for MEDLINE]
2.

Recent advances in combined modality therapy for locally advanced head and neck cancer.

Wirth LJ, Posner MR.

Curr Cancer Drug Targets. 2007 Nov;7(7):674-80. Review.

PMID:
18045072
[PubMed - indexed for MEDLINE]
3.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
[PubMed - indexed for MEDLINE]
4.

Radiotherapy for head and neck cancer: latest developments and future perspectives.

Bernier J, Bentzen SM.

Curr Opin Oncol. 2006 May;18(3):240-6. Review.

PMID:
16552235
[PubMed - indexed for MEDLINE]
5.

[Development of treatments for head and neck squamous cell carcinomas].

Tsukuda M.

Gan To Kagaku Ryoho. 1999 Jun;26 Suppl 1:85-96. Review. Japanese.

PMID:
10410663
[PubMed - indexed for MEDLINE]
6.

Head and neck squamous cell carcinoma: optimizing the therapeutic index.

Rosenthal DI, Blanco AI.

Expert Rev Anticancer Ther. 2005 Jun;5(3):501-14. Review.

PMID:
16001957
[PubMed - indexed for MEDLINE]
7.

Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer.

Jain P, Kumar P, Pai VR, Parikh PM.

Indian J Cancer. 2008 Jul-Sep;45(3):83-9.

PMID:
19018109
[PubMed - indexed for MEDLINE]
Free Article
8.

Molecular targeted therapies in all histologies of head and neck cancers: an update.

Razak AR, Siu LL, Le Tourneau C.

Curr Opin Oncol. 2010 May;22(3):212-20. doi: 10.1097/CCO.0b013e328338001f. Review.

PMID:
20173639
[PubMed - indexed for MEDLINE]
9.

Evidence-based radiation oncology in head and neck squamous cell carcinoma.

Corvò R.

Radiother Oncol. 2007 Oct;85(1):156-70. Epub 2007 May 4. Review.

PMID:
17482300
[PubMed - indexed for MEDLINE]
10.

Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

Hainsworth JD, Meluch AA, McClurkan S, Gray JR, Stroup SL, Burris HA 3rd, Yardley DA, Bradof JE, Yost K, Ellis JK, Greco FA.

Cancer J. 2002 Jul-Aug;8(4):311-21.

PMID:
12184409
[PubMed - indexed for MEDLINE]
11.

Multidisciplinary Symposium on Head and Neck Cancer. 2 December 2005, Philadelphia, PA, USA.

Agulnik M, Siu LL.

Expert Opin Pharmacother. 2006 Mar;7(4):489-94.

PMID:
16503821
[PubMed - indexed for MEDLINE]
12.

Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.

Nguyen NP, Vos P, Lee H, Borok TL, Karlsson U, Martinez T, Welsh J, Cohen D, Hamilton R, Nguyen N, Nguyen LM, Vinh-Hung V.

Oncology. 2008;75(3-4):186-91. doi: 10.1159/000163058. Epub 2008 Oct 8.

PMID:
18841033
[PubMed - indexed for MEDLINE]
13.

Treatment of locally advanced head and neck cancer: historical and critical review.

Al-Sarraf M.

Cancer Control. 2002 Sep-Oct;9(5):387-99. Review.

PMID:
12410178
[PubMed - indexed for MEDLINE]
Free Article
14.

Induction chemotherapy for head and neck cancer: will history repeat itself?

Argiris A.

J Natl Compr Canc Netw. 2005 May;3(3):393-403. Review. Erratum in: J Natl Compr Canc Netw. 2005 Jul;3(4):table of contents.

PMID:
16002005
[PubMed - indexed for MEDLINE]
15.

Supportive care in head and neck oncology.

de Castro G Jr, Guindalini RS.

Curr Opin Oncol. 2010 May;22(3):221-5. doi: 10.1097/CCO.0b013e32833818ff. Review.

PMID:
20186057
[PubMed - indexed for MEDLINE]
16.

Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.

Fu KK, Cooper JS, Marcial VA, Laramore GE, Pajak TF, Jacobs J, Al-Sarraf M, Forastiere AA, Cox JD.

Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):425-38.

PMID:
8655364
[PubMed - indexed for MEDLINE]
17.

New cytotoxic and molecular-targeted therapies of head and neck tumors.

Caponigro F, Ionna F, Comella G.

Curr Opin Oncol. 2004 May;16(3):225-30. Review.

PMID:
15069317
[PubMed - indexed for MEDLINE]
18.

Incorporation of molecularly targeted agents in the primary treatment of squamous cell carcinomas of the head and neck.

Bernier J.

Hematol Oncol Clin North Am. 2008 Dec;22(6):1193-208, ix. doi: 10.1016/j.hoc.2008.08.003. Review.

PMID:
19010268
[PubMed - indexed for MEDLINE]
19.

Overview of combined modality therapies for head and neck cancer.

Dimery IW, Hong WK.

J Natl Cancer Inst. 1993 Jan 20;85(2):95-111. Review.

PMID:
8418313
[PubMed - indexed for MEDLINE]
20.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk